EGFR and hepatocellular carcinoma: Also, inhibition of EGFR/MET made HCCLM3 cell lines more easily killed by leukocytes and more leukocytes could survive (Fig. 3D), which were not beneficial to hematogenous metastasis of HCC cell lines.